Сравнительный анализ структуры наследственной компоненты подверженности к бронхиальной астме и туберкулезу по генам ферментов метаболизма ксенобиотиков

190. Moffatt M. F., Schou C., Faux J. A. et al. Germline TCR-A restriction of immunoglobulin E responses to allergen // Immunogenetics. - 1997. - № 46. - P. 226-230.

191. Morgenstern R., DePierre J. W. Microsomal glutathione S-transferase // Rev. Biochem. Toxicol. - 1985. - V. 7. - P. 67-103.

192. Morita S., Yano M., Shiozaki et al. CYP1A1, CYP2E1 and GSTM1 polymorphisms are not associated with susceptibility to squamouscell carcinoma of the esophagus // Int. J. Cancer. - 1997. - V. 71. - P. 192-195.

193. Munaka M., Kohshi K., Kawamoto T et al. Genetic polymorphisms of tobacco- and alcohol-related metabolizing enzymes and the risk of hapatocellular carcinoma // Journal of cancer research and clinical oncology. - 2003. - V. 129. - №. 6. - P. 355-360.

194. Mutmansky J.M. The war on black lung // Earth and Miner. Sci. - 1990. - V. 59. - P. 6-10.

195. Nanavaty U., Goldstein A.D., Levine S.J. Polymorphisms in candidate asthma genes // Am. J. Med. Sci. - 2001. - V. 321. - P. 11-16.

196. Nebert D. W., Jorge-Nebert L., Vesell E. S. Pharmacogenomics and “Individualized drug therapy” // Am. J. Pharmacogenomics. - 2003. - V. 3. - № 6. - P. 361-370.

197. Nebert D.W. Polymorphisms in drug-metabolizing enzymes: what is their clinical relevance and why do they exist? // Am. J. Hum. Genet. - 1997. - № 60. - P. 265-271.

198. Nelson D. R., Koymans L., Kamataki T. et al. P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature // Pharmacogenetics. - 1996. - V. 6. - P. 1-42.

199. Nickel R. G., Casolaro V., Wahn U. et al. Atopic dermatitis is associated with a functional mutation in the promoter of the C-C chemokine RANTES // J. Immunol. - 2000. - № 164. - P. 1612-1616.

200. Nicolae D., Cox N.J., Lester L. et al. A fine mapping and positional candidate studies identify HLA-G as an asthma susceptibility gene on chromosome 6p21 // Am. J. Hum. Genet. - 2005. - V. 76. - № 2. - P. - 349-57.

201. Nieminen M. M., Kaprio J., Koskenvuo M. A population-based study of bronchial asthma in adult twin pairs // Chest. - 1991. - V. 100. - P. 70-75.

202. Noguchi E., Shibasaki M., Arinami T. et al. Assotiation of asthma and the interleukin-4 promoter gene in Japanese // Clin Exp Allergy. - 1998. - 28. - P. 449-453.

203. North R .J., Medina E. How important is Nramp1 in tuberculosis? // Trends in Microbiology. - 1998. - V. 6. - №11. - P. 441-443.

204. Obase Y., Shimoda T., Kawano T. et al. Polymorphisms in the CYP1A2 gene and theophylline metabolism in patients with asthma // Clin Pharmacol Ther. - 2003. - V. 73. - № 5. - P. 468-474.

205. Ober C., Cox N. J., Abney M. et al. Genome-wide search for asthma susceptibility loci in a founder population. The Collaborative Study on the Genetics of Asthma // Hum. Mol. Genet. - 1998. - V. 7. - P1393-1398.

206. Ober S., Leavitt S. A., Tsaienko A. et al., Variation in the interleukin 4-receptor alpha gene confers susceptibility to asthma and atopy in ethnically diverse populations // Am. J. Hum. Genet. - 2000. - № 66. - P. 517-526.

207. Organov R.G., Maslennikova G. Ya. // Eur. Respir. J. - 1999. - V. 13. - № 2. - P. 287- 289.

208. Paigen K.and Eppig J. T. A mouse phenome project / Mamm. Genome. - 2000. - V. 11. - № 9. - P. 715-717.

209. Park J.Y., Schantz S.P., Stern J.C. et al., Assotiation between glutathione S-transferase pi genetic polymorphism and oral cancer risk // Pharmacogenerics. - 2000. - V. 10. - № 4. - P. 374.

210. Pearce N. What does the odds ratio estimate in a case-control study? // Int. J. Epidemiol. - 1993. - V. 26 № 6. - P. 1189-1192.

211. Pelkonen O., Raunio H. Metabolic activation of toxins: tissue-specific expression and metabolism in target organs // Environ. Health Perspect. - 1997. - V. 105. - Suppl. 4. - P. 767-774.

212. Pemble S., Schroeder K.R., Spencer S.R. et al. Human glutathione S-transferase theta (GSTT1): cDNA cloning and the characterization of a genetic polymorphism // Biochem J. - 1994. - V. 300. - P. 271-276.

213. Pillai S. G, Cousens D. J, Barnes A. A. A coding polymorphism in the CYSLT2 receptor with reduced affinity to LTD4 is associated with asthma // Pharmacogenetics. - 2004. - V. 14. - № 9. - P. - 627-633.

214. Poland A., Glover E., Robinson J. R. et al. Genetic expression of aryl hydrocarbon hydroxylase activity, induction of monooxygenase activities and cytochrome P450 formation by 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin in mice genetically “non-resposive” to others aromatic hydrocarbons // J. Biol. Chem. - 1973. - V. 249. - P. 5599-5606.

215. Prandota J. Important role of prodromal viral infection responsible for inhibition of xenobiotic metabolizing enzymes in the pathomechanism of idiopathic Reye's syndrome, Stevens-Johanson syndrome, autoimmune hepatits and hepatotoxicity of therapeutic doses of acetaminophen used in genetically predposed persos // Am. J. Ther. - 2002. - V. 9. - P. 149-156.

216. Pykalainen M, Kinos R, Valkonen S. et al. Association analysis of common variants of STAT6, GATA3, and STAT4 to asthma and high serum IgE phenotypes // J. Allergy Clin. Immunol. - 2005. - V. 115. - № 1. - P. - 80-87.

217. Quanjer P.H., Tammeling G.L., Cotes J.E. et al. Lung volumes and ventilatory flows // Eur. Respir. J. - 1993. - V. 6. - P. 4-40.

218. Ramsey C.D., Lazarus R., Camargo C.A. et al. Polymorphisms in the interleukin 17F gene (IL17F) and asthma // Genes Immun. - 2005. - V. 6. - № 3. - P. 236-241.

219. Raunio H., Husgafvel-Pursianen, Anttila S. et al. Diagnosis of polymorphisms in carcinogen-activating and inactivating enzymes and cancer susceptibility - a review // Gene. - 1995. - V. 159. - P. 113-121.

220. Ravindranath V. Metabolism of xenobiotics in the central nervous system: implications and challenges // Biochem. Pharmacol. - 1998. - V. 56. - P. 547-551.

221. Reihsaus E., Innis M., Macintyre N. et al. Mutations in the gene encoding for the beta 2-adrenergic receptor in normal and asthmatic subjects // Am. J. Respir. Cell Mol. Biol. - 1993. - V. 8. - P. 334 -339.

222. Renton K.W. Cytochrome P450 regulation and drug biotransformation during inflammation and infection // Curr Drug Metab. - 2004. - V. 5. № 3. - P. 235-243.

223. Richardson T.H., Jung F., Griffin K.J. et al. A universal approach to the expression of human and rabbit cytochrome P450s of the 2C subfamily in Escherichia coli // Arch. Biochem. Biophys. - 1995. - V. 323. - № 1. - P. 87-96.

224. Richter-Hintz D., Their R., Steinwachs S. et al. Allelic variants of drug metabolizing enzymes as risk factors in psoriasis // Journal of Investigative Dermatology. - 2003. - V. 120. - P. 765-770.

225. Rifkind A. B., Lee C., Chang T. K. and Waxman D. J. Arachidonic acid metabolism by human cytochrome P450s 2C8, 2C9, 2E1, and 1A2: regioselective oxygenation and evidence for a role for CYP2C enzymes in arachidonic acid epoxygenation in human liver microsomes // Arch Biochem Biophys. -1995. - V. 320. - № 3. - P. 380-389.

226. Rollinson S., Levene A. P., Mensah F. K., Roddam P. L. et al. Gastric marginal zone lymphoma is associated with polymorphisms in genes involved in inflammatory response and antioxidative capacity // Blood. - 2003. - V. 102. - № 3. - P. 1007-1011.

227. Romkes M., Faletto M.B., Blaisdell I.A. et al. Cloning and expression of the complementary DNAs for multiple members of the human cytochrome P450IIC subfamily // Biochemistry. - 1991. - V. 30. № 13. - P. 3247-55.

228. Rosenwasser L. J., Klemm D. J., Dresback J. K. et al. Promoter polymorphisms in the chromosome 5 gene cluster in asthma and atopy // Clin. Exp. Allergy. - 1995. - № 25 (suppl 2). - P. 74-78.

229. Roy B., Chowdhury A., Kundu S. et al. Increased risk of antituberculosis drug-induced hepatotoxicity in individuals with glutathione S-transferase M1 “null” mutation // Journal of Gastroenterology and Hepatology. - 2001. - V. 16. - P. 1033-1037.

230. Ryu S., Park Y.-K., Bai G. H. et al. 3' UTR polymorphisms in the NRAMP1 gene are associated with susceptibility to tuberculosis in Koreans // Int. J. Tuberc. Lung. Dis. - 2000. - V. 4. - № 6. - P. 577-580.

231. Saito K. Shinoharaet A., Kamataki T. et al. N-hydroxylanine O-acetyltransferase in hamster liver: identity with arylhydroxamic acid N,O-acetyltransferase and arylamine N- acetyltransferase // J. Biochem. - 1986. - V. 99. - № 6. - P. 1689-1697.

232. Salama S. A., Sierra-Torres C. H., Oh H-Y. et al. A multiplex-PCR/RFLP procedure for simultaneous CYP2E1, mEH and GSTM1 genotyping // Cancer Lett. - 1999. - V. 143. - P. 51-56.

233. Sandford A. J., Silverman E. K. Chronic obstructive pulmonary disease. 1: Susceptibility factors for COPD the genotype-environment interaction // Thorax. - 2002. - V. 57. - № 8. - P. 736-741.

234. Sandford A.J., Weir T.D., Pare P.D. et al. State of the Art. The genetics of asthma // Am. J. Respir. Crit. Care Med. - 1996. - V. 13. - P. 1749-1765.

235. Schwab M., Schaeffeler E., Klotz U. et al. CYP2C19 polymorphism is a major predictor of treatment failure in white patients by use of lansoprazole-based quadruple therapy for eradication of Helicobacter pylori // Clin Pharmacol Ther. - 2004. - V. 76. - P.201-209.

236. Schwartz D.A., Freedman J.H. and Linney E.A. Environmental genomics; a key to understanding biology, pathophysiology and disease // Hum. Mol. Genet. - 2004. - V. 13. - P. 217-224.

237. Seidegard J., Vorachek W.R., Pero R.W. et al. Hereditary differences in the expression of human glutathione transferase activity on trans-stilbene oxide are due to a gene deletion // Proc. Nat. Acad. Sci. USA. - 1988. - V. 85. - P. 7293-7297.

238. Senak M., Pierzchalska M., Bazan-Socha S. et al. Enhanced expression of the leukotriene C(4) synthase due to overactive transcription of an allelic variant associated with aspirin-intolerant asthma // Am. J. Respir. Cell Mol. Biol. - 2000. - № 23. - P. 290-296.

239. Sengler C. Lau S., Wan U. et al. Interactions between genes and environmental factors in asthma and atopy: new developments // Respir. Res. - 2002. - V. 3. № 7. - P. 7.

240. Shields P.G., Caporaso N.E., Falk R.T. et al. Lung cancer, race and CYP1A1 genetic polymorphism // Cancer Epidemiol. Biomarkers and Prev. - 1993. - № 2 - P. 481-485.

241. Shirakawa T., Enomoto T., Shimazu S. et al. The inverse assotiation between tuberculin responses and atopic disorder // Science. - 1997. - V. 275. - P. 77-79.

242. Shirakawa T., Li A., Dubowitz M. Association between atopy and variants of the beta subunit of the high-affinity immunoglobulin E receptor // Nat. Genet. - 1994. - № 7. - P. 125-129.

243. Shirakawa T., Mao X.Q., Sasaki S. et al. Association between atopic asthma and a coding variant of Fc epsilon RI beta in a Japanese population [letter] // Hum. Molecular Genet. - 1996. - № 5. - P. 2068.

244. Sipes I.G., Gandolfi A.J. Biotransformation of toxicants // Casarett and Doull's toxicology. - N. Y.: Macmillan Publishing Company. -1986. - P. 99-173.

245. Skadhauge L. R., Christens K., Kyvik K. O. et al. Genetic and environmental influence on asthma: a population-based study of 11,688 Danish twin pairs // Eur. Respir. J. - 1999. - V. 13. - P. 8-14.

246. Sodhi C.P., Rana S.V., Mehta S. Study of oxidative stress in rifampicin induced hepatic injury in growing rats with and without protein energy malnutrition // Hum. Exp. Toxicol. - 1997. - № 20. - P. 315-321.

247. Sodhi C.P., Rana S.V., Mehta S.K. et al. Study of oxidative stress in izoniazid induced hepatic injury in young rats with and without protein energy malnutrition // J. Biochem. Toxicol. - 1996. - № 11. - P. 139-146.

248. Spielman R.S., McGunis R.E., Ewens W.J. Transmission test for linkage disequilibrium: The insulin gene region and insulin-dependent diabetes-mellitus (IDDM) // Am. J. Hum. Genet. - 1993. - V. 52. - P. 506-516.

249. Spitx M.R., Duphrone C.M., Detry M.A. et al. Dietary intake of isothiocyanates: evidence of a joint effect with glutathione S-transferase polymorphisms in lung cancer risk // Cancer Epidemiology, Biomarkers Prevention. - 2000. - V. 9. - P. 1017-1020.

250. Spurdle A.B., Chen X., Abbazadegan M. et al. CYP17 promoter polymorphism and ovarian cancer risk // Int. J. Cancer. - 2000. - V. 86. - P. 436-439.

251. Stead W.W. Genetics and resistance to tuberculosis: could resistance be enhanced by genetics engineering? // Ann. Int. Med. - 1992. - V. 116. - P. 937-941.

252. Steele M.A., Burk R.F., Desprez R.M. et al. Toxic hepatitis with isoniazid and rifampicin - a meta analysis // Chest. - 1991. - № 99. - P. 465-471.

253. Sterk P.J., Fabbri L.M., Quanjer P.H. et al. Airway responsiveness // Eur. Respir. J. - 1993. - V. 6. Suppl. - P. 55-64.

254. Strachan D.P. Hayfever, hygiene, and household size // Biol.Med.J. - 1989. - V. 299. - P. 1259-1260.

255. Sugimura H., Suzuki I., Hamada G.S. et al. Cytochrome P450 IAI genotype in lung cancer patients and controls in Rio de Janeiro, Brazil // Cancer Epidemiol. Biomarkers and Prev. - 1994. - № 3. - P. 145-148.

256. Summerhill E., Levitt S. A., Gidley H. et al. Beta(2)-adrenergic receptor Arg16/Arg16 genotype is associated with reduced lung function, but not with asthma, in the Hutterites // Am. J. Respir. Crit Care Med. - 2000. - V. 162. - P. 599-602.

257. Surry D.D., Neneses-Lorente G., Heavens R. et al. Rapid determination of rat hepatocyte mRNA induction potential using oligonucleotide probes for CYP1A1, 1A2, 3A, and 4A1 // Xenobiotica. - 2000. - V. 30. - № 5. - P. 441-456.

258. Tamer L., Calikoglu M., Ates N. A. et al. Glutathione S-transferase gene polymorphisms (GSTT1, GSTM1, GSTP1) as increased risk factors for asthma // Respirology. - 2004. - V. 9. - № 4. - P. 493-498.

259. Tanaka K., Sugiura H., Uehara M. et al. Association between mast cell chymase genotype and atopic eczema: alone and those with atopic eczema and atopic respiratory disease // Clin. Exp. Allergy. - 1999. - V. 29. - P. 800-803.

260. The Collaborative Study in the Genetics of Asthma. A genome-wide search for allergic response (atopy) genes in three ethnic groups // Hum. Genet. - 2004. - V. 114. - P. 157-164.

261. The Collaborative Study on the Genetics of Asthma. A genome-wide search for asthma susceptibility loci in ethnically diverse populations. // Nat. Genet. - 1997. - V. 15. - P. 389-392.

262. Thomas N.S., Wilkinson J., Holgate S.T. The candidate region approach to the genetics of asthma and allergy. // Am. J. Respir. Crit Care Med. - 1997. - V. 156. - P. 144-151

263. To-Figueras J., Gene M., Gomez-Catalan J. Glutathione-S-transferase M1 and codon 72 p53 polymorphisms in a northwestern Mediterranean population and their relation to lang cancer susceptibility // Cancer Epidemiol. Biomark. Prev. - 1996. - V. 5. - P. 337-342.

264. Urs A. Molecular mechanisms of genetic polymorphisms of drug metabolism // Annu. Rev. Pharmacol. Toxicol. - 1997. - V. 37. - P. 169-196.

265. Van der Pouw Kraan T.C., Van Veen A., Boeije L.C. et al. An IL13 promoter polymorphism associated with increased risk of allergic asthma // Gene Immun. - 1999. - № 1. - P. 61-65.

266. Von Hertzen L., Klaukka T., Mattila H. et al. Mycobacterium tuberculosis infection and the subsequent development of asthma and allergic conditions // J. Allergy Clin. Immunol. - 1999. - V. 104. - № 6. - P. 1211-1214.

267. Von Mutius E., Martinez F. D., Fritzsch C. et al. Prevalence of asthma and atopy in two areas of West and East Germany // Am. J. Respir. Crit. Care Med. - 1994. - V. 149. - № 2. - P. 358-364.

268. Watanabe J., Hayashi S., Kawajiri K. Different regulation and expression of the human CYP2E1 gene due to the RsaI polymorphism in the 5'-flanking region // J. Biochem. - 1994. - V. 116. - P. 321-326.

269. Watson M. A., Stewart R. K., Smith G. B. J. et al. Human glutathione S-transferase P1 polymorphism: relationship to lung tissue enzyme activity and population freguency distribution // Carcinogenesis. - 1998. - V. 19. - P. 275-280.

270. Waxman D.J. and Azaroff L. Phenobarbital induction of cytochrome P-450 gene expression. Biochem .J. - 1992. - V. 281. - P. 577-592.

271. Wen X., Wang J.S., Neuvonen J. et al. Isoniazid is a mechanism-based inhibitor of cytochrome P450 1A2, 2A6, 2C19 and 3A4 isoforms in human liver microsomes // Eur. J. Clin. Pharmacol. - 2002. - V. 57. № 11. - Р. 799 - 804.

272. Wheeler C., Guenthner T.M. Cytochrome P450-dependet metabolism of xenobiotic in human lung // J. Biochem. Toxicol. - 1991. - V. 6. - P. 163-169.

273. Whitlock J.P., Gelboin H.V. Aryl hydrocarbon (benzo[б]pyrene hydroxilase in rat liver cells in culture // J. Biol. Chem. - 1974. - V. 249. - P. 2616-2623.

274. Wilson M. H., Grant P.J., Hardine L.J. et al. Glutathione S-transferase M1 null genotype is associated with a decreased risk of myocardial infarction // The FASEB Journal. - 2000. - Vol. 14. - P. 791-796.

275. Wjst M., Fischer G., Immervoll T. et al. A genome-wide search for linkage to asthma. German Asthma Genetics Group // Genomics. - 1999. - V. 58. - P. 1-8.

276. Wright D.T., Cohn L.A., Li H. et al. Interactions of oxygen radicals with airway epithelium // Environ. Health Perspect. - 1994. - V. 102 (Suppl.10). - P. 85-90.

277. Xie H. G., Kim R. B., Stein C. M. et al. Genetic polymorphism of (S)-mephenytoin 4'-hydroxylation in populations of African descent // Br. J. Clin. Pharmacol. - 1999. - V. 48. - № 3. - P. 402-406.

278. Xu X., Kelsey K.T., Wiencke J.K. et al. Cytochrome P450 CYP1A1 MspI polymorphism and lung cancer susceptibility // Cancer Epidemiology, Biomarkers Prevention. - 1996. - V. 5. - P. 687-692.

279. Yan L., Galinsky R. E., Bemstein J. A. et al. Histamine N-methyltransferase pharmacogenetics: assotiation of a common functional polymorphism with asthma // Pharmacogenetics. - 2000. - № 10. - P. 261-266.

280. Yang Y. S., Wong L. P., Lee T. C. et al. Genetic polymorphism of cytochrome P450 2C19 in healthy Malaysian subjects // Br. J. Clin. Pharmacol. - 2004. - V. 58. - № 3. - P. 332-335.

281. Yokouchi Y., Nukaga Y., Shibasaki M. et al. Significant evidence for linkage of mite-sensetive childhood asthma to chromosome 5q31-q33 near the interleukin 12 B locus by a genome-wide search in Japanese families // Genomics. - 2000. - V. 66. - P. 152-160.

282. Zhang YQ, Sun BY, Dai J.J. Studies on the genetic diathesis of asthma bronchial // Yi Chuan. - 2004. - № 26. - V. 2. - P. 147-150.

283. Zhou W., Liu G., Thurston S.W. et al. Genetic polymorphisms in N-acetyltransferase-2 and microsomal epoxide hydrolase, cumulative cigarette smoking, and lung cancer // Cancer Epidemiology, Biomarkers Prevention. - 2002. - V. 11. - P. 15-21.

БЛАГОДАРНОСТИ

Автор считает приятным долгом выразить огромную признательность своему руководителю - академику РАМН, профессору Пузыреву Валерию Павловичу за поддержку, чуткое отношение и неоценимую помощь в планировании, выполнении и обсуждении работы. Выражаю искреннюю благодарность сотрудникам лаборатории популяционной генетики ГУ НИИ МГ ТНЦ СО РАМН за предоставление материала и сопутствующей информации, а также за помощь в обсуждении полученных результатов.

Отдельную благодарность за предоставление клинического материала сотрудникам кафедры фтизиатрии Сибирского государственного медицинского университета (заведующий - член-корр. РАМН, профессор Стрелис А.К.) и сотрудникам кафедры факультетской педиатрии с курсом детских болезней лечебного факультета (заведующий - д.м.н., профессор Огородова Л.М.) Сибирского государственного медицинского университета, а также областного детского центра клинической иммунологии и аллергологии (Областная детская больница, г. Томск, главный врач - Сальников В.А.).